BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 37459311)

  • 1. Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda.
    Mayanja Y; Rida W; Kimani J; Ssetala A; Mpendo J; Nanvubya A; Mutua G; Anzala O; Price MA
    PLoS One; 2023; 18(7):e0288604. PubMed ID: 37459311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.
    Seremba E; Ocama P; Ssekitoleko R; Mayanja-Kizza H; Adams SV; Orem J; Katabira E; Reynolds SJ; Nabatanzi R; Casper C; Phipps W
    Vaccine; 2021 Feb; 39(8):1265-1271. PubMed ID: 33516601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
    Seremba E; Van Geertruyden JP; Ssenyonga R; Opio CK; Kaducu JM; Sempa JB; Colebunders R; Ocama P
    Vaccine; 2017 May; 35(22):2937-2942. PubMed ID: 28434689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sero-prevalence of hepatitis B virus and compliance with hepatitis B vaccination schedules among outpatient clinic attendees in Nairobi.
    Langat B; Muge EK; Night D; Okoth F; Ochwedo KO; Songok EM
    PLoS One; 2023; 18(2):e0281256. PubMed ID: 36730277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus and sexual behavior in Rakai, Uganda.
    Stabinski L; Reynolds SJ; Ocama P; Laeyendecker O; Serwadda D; Gray RH; Wawer M; Thomas DL; Quinn TC; Kirk GD
    J Med Virol; 2011 May; 83(5):796-800. PubMed ID: 21412787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya.
    Muriuki BM; Gicheru MM; Wachira D; Nyamache AK; Khamadi SA
    BMC Res Notes; 2013 Sep; 6():363. PubMed ID: 24016453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B virus infection and uptake of hepatitis B vaccine among healthcare workers, Makueni County, Kenya 2017.
    Kisangau EN; Awour A; Juma B; Odhiambo D; Muasya T; Kiio SN; Too R; Lowther SA
    J Public Health (Oxf); 2019 Dec; 41(4):765-771. PubMed ID: 30351408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.
    Freitas SZ; Soares CC; Tanaka TS; Lindenberg AS; Teles SA; Torres MS; Mello FC; Mendes-Corrêa MC; Savassi-Ribas F; Motta-Castro AR
    Braz J Infect Dis; 2014; 18(5):473-80. PubMed ID: 24662138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
    Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
    BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hepatitis B virus infection in a Kenyan cohort of HIV infected anti-retroviral therapy naïve adults.
    Salyani A; Shah J; Adam R; Otieno G; Mbugua E; Shah R
    PLoS One; 2021; 16(1):e0244947. PubMed ID: 33406137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon.
    Tatsilong HO; Noubiap JJ; Nansseu JR; Aminde LN; Bigna JJ; Ndze VN; Moyou RS
    BMC Public Health; 2016 Aug; 15():706. PubMed ID: 27487845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa.
    Coffie PA; Egger M; Vinikoor MJ; Zannou M; Diero L; Patassi A; Kuniholm MH; Seydi M; Bado G; Ocama P; Andersson MI; Messou E; Minga A; Easterbrook P; Anastos K; Dabis F; Wandeler G;
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):706. PubMed ID: 29143625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus infection and factors associated with its acquisition among adults in a Lake Victoria HIV hyperendemic fishing community in Kyotera district, Uganda: a cross-sectional observation.
    Ssuuna C; Ssempijja V; Kalibbala S; Serwadda D; Yeh PT; Wawer M; Gray R; Chang L; Kagaayi J; Reynolds S
    BMJ Open; 2022 Apr; 12(4):e050436. PubMed ID: 35393306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya.
    Kerubo G; Khamadi S; Okoth V; Madise N; Ezeh A; Ziraba A; Mwau M
    PLoS One; 2015; 10(6):e0129247. PubMed ID: 26068212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cango Lyec (Healing the Elephant): Chronic Hepatitis B Virus among post-conflict affected populations living in mid-Northern Uganda.
    Malamba SS; Muyinda H; Ogwang DM; Katamba A; Zamar DS; Jongbloed K; Sewankambo NK; Schechter MT; Spittal PM
    PLoS One; 2021; 16(5):e0251573. PubMed ID: 34043637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
    J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination coverage and immunity against hepatitis B among HIV-infected patients in South Brazil.
    Martins S; Livramento Ad; Andrigueti M; Kretzer IF; Machado MJ; Spada C; Treitinger A
    Braz J Infect Dis; 2015; 19(2):181-6. PubMed ID: 25626960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
    Argaw B; Mihret A; Aseffa A; Tarekegne A; Hussen S; Wachamo D; Shimelis T; Howe R
    BMC Infect Dis; 2020 Jul; 20(1):528. PubMed ID: 32698884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.